Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Paclitaxel
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(4)
+
-
Creation Date
2015
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(6)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(6)
+
-
Topic
Paclitaxel
(7)
+
-
Bevacizumab
(3)
+
-
Cisplatin
(2)
+
-
Author
E. boven
(3)
+
-
Lam, S.W.
(3)
+
-
Jager, A.
(2)
+
-
Kroep, J.R.
(2)
+
-
Linn, S.C.
(2)
+
-
Tinteren, H. van
(2)
+
-
Show more
Language
en
(7)
+
-
Search results
(1 - 7 of 7)
show grid
show list
save search
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer
Comparable effectiveness of 45-and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia
Carboplatin-cyclophosphamide or paclitaxel without or with bevacizumab as first-line treatment for metastatic triple-negative breast cancer (BOOG 2013-01)
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review
Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial